Use of antipsychotic drugs in dermatology.
Sign Up to like & getrecommendations! Published in 2018 at "Clinics in dermatology"
DOI: 10.1016/j.clindermatol.2018.08.006
Abstract: Antipsychotic drugs can be beneficial in dermatology because of their both central nervous system and peripheral effects. All antipsychotic drugs have a central postsynaptic dopamine D2 receptor blocking effect, which underlies their antipsychotic action. The… read more here.
Keywords: dermatology; receptor blocking; effect; dermatology use ... See more keywords
Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001061
Abstract: Supplemental digital content is available in the text. Abstract Purpose/Background Dopamine receptor blocking agents (DRBAs), also known as antipsychotics, are medications widely used to treat a growing number of mental health diagnoses. However, their utility… read more here.
Keywords: movement; receptor blocking; epss omds; dopamine receptor ... See more keywords
Time-to-therapy discontinuation in patients newly diagnosed with schizophrenia initiated on long-acting injectable versus oral dopamine receptor blocking agents.
Sign Up to like & getrecommendations! Published in 2023 at "Early intervention in psychiatry"
DOI: 10.1111/eip.13384
Abstract: AIM The purpose of this project is to assess the time-to-therapy discontinuation and hospital readmission rate among patients newly diagnosed with schizophrenia who are prescribed long-acting injectable versus oral dopamine receptor blocking agents. METHODS A… read more here.
Keywords: time; dopamine receptor; blocking agents; receptor blocking ... See more keywords
Graves Disease With Thyroid-Stimulating Hormone Receptor–Blocking Autoantibodies During Pregnancy
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Internal Medicine"
DOI: 10.7326/l19-0818
Abstract: Receptor–Blocking Autoantibodies During Pregnancy Background: Graves disease is an autoimmune disease caused by thyroid-stimulating hormone receptor antibodies (TSH-R-Ab), which can be stimulating (TSAb), neutral, or blocking (TBAb). The net antibody activity determines the clinical phenotype.… read more here.
Keywords: thyroid stimulating; receptor blocking; graves disease; autoantibodies pregnancy ... See more keywords